UV Flu Technologies, Inc. (UVFT)

Market Cap	26.83K
Revenue (ttm)	194.75K
Net Income (ttm)	-750.44K
Shares Out	134.16M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,500
Average Volume	29,146
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0002
Beta	-66.37
RSI	62.51
Earnings Date	n/a

About UV Flu Technologies

UV Flu Technologies, Inc. engages in the research, development, manufacture, and sale of air purification systems and products primarily in the United States. Its flagship product is the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation inside a killing chamber that goes beyond filtering to trap and destroy harmful microbes. The company also offers RX Air product line, which include HEPA based air purifiers. Its products are used in hotels, hair and nail salons, pet kennels, test labs, hospitals, restaurants, casin...

• Industry: Pollution & Treatment Controls
• Sector: Industrials
• Founded: 2006
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: UVFT

Financial Performance

In 2015, UV Flu Technologies's revenue was $175,513, an increase of 54.31% compared to the previous year's $113,743. Losses were -$946,666, -4.70% less than in 2014.